Shuo Cong, Fan Yu, En Ping Yap, Valerie Ho, Myu Mai Ja Kp, Derek Hausenloy, Chrishan Ramachandra
{"title":"10048:恩格列净改善了糖尿病心力衰竭患者的人诱导多能干细胞来源的心肌细胞的病理表型","authors":"Shuo Cong, Fan Yu, En Ping Yap, Valerie Ho, Myu Mai Ja Kp, Derek Hausenloy, Chrishan Ramachandra","doi":"10.1016/j.jmccpl.2024.100170","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"10 ","pages":"Article 100170"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"10048: Empagliflozin ameliorates the pathological phenotype in human induced pluripotent stem cell-derived cardiomyocytes generated from patients with diabetic heart failure\",\"authors\":\"Shuo Cong, Fan Yu, En Ping Yap, Valerie Ho, Myu Mai Ja Kp, Derek Hausenloy, Chrishan Ramachandra\",\"doi\":\"10.1016/j.jmccpl.2024.100170\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":73835,\"journal\":{\"name\":\"Journal of molecular and cellular cardiology plus\",\"volume\":\"10 \",\"pages\":\"Article 100170\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of molecular and cellular cardiology plus\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S277297612400117X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of molecular and cellular cardiology plus","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S277297612400117X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
10048: Empagliflozin ameliorates the pathological phenotype in human induced pluripotent stem cell-derived cardiomyocytes generated from patients with diabetic heart failure